NTLA
Intellia Therapeutics Inc. Earnings
$7.23
Earnings Summary
Revenue | $12.87Mn |
Net Profits | $-128.9Mn |
Net Profit Margins | -1001.23% |
Intellia Therapeutics Inc.’s revenue jumped 771.57% since last year same period to $12.87Mn in the Q4 2024. On a quarterly growth basis, Intellia Therapeutics Inc. has generated 41.3% jump in its revenue since last 3-months.
Intellia Therapeutics Inc.’s net profit jumped 2.47% since last year same period to $-128.9Mn in the Q4 2024. On a quarterly growth basis, Intellia Therapeutics Inc. has generated 5.02% jump in its net profits since last 3-months.
Intellia Therapeutics Inc.’s net profit margin fell -114.52% since last year same period to -1001.23% in the Q4 2024. On a quarterly growth basis, Intellia Therapeutics Inc. has generated 32.78% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
EPS Estimate Current Quarter | -1.32 |
EPS Estimate Current Year | -1.32 |
Intellia Therapeutics Inc.’s earning per share (EPS) estimates for the current quarter stand at -1.32 - a 4.61% jump from last quarter’s estimates.
Intellia Therapeutics Inc.’s earning per share (EPS) estimates for the current year stand at -1.32.
Key Ratios
Earning Per Share (EPS) | -1.27 |
Intellia Therapeutics Inc.’s earning per share (EPS) jumped 13.01% since last year same period to -1.27 in the Q4 2024. This indicates that the Intellia Therapeutics Inc. has generated 13.01% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2024-05-09 | -1.38 | -1.12 | 18.84% |
2024-08-08 | -1.23 | -1.52 | -23.58% |
2025-02-27 | -1.32 | -1.27 | 3.52% |
2024-11-07 | -1.38 | -1.34 | 2.9% |
